<DOC>
	<DOC>NCT02233920</DOC>
	<brief_summary>Study to obtain further information on the tolerability and efficacy of Ventilat® metered-dose inhaler in the treatment of Chronic Obstructive bronchitis under conditions of daily practice</brief_summary>
	<brief_title>Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Bronchitis, Chronic</mesh_term>
	<mesh_term>Oxitropium</mesh_term>
	<criteria>Primarily Patients of both genders older than 40 years, who suffer from Chronic Obstructive bronchitis Only patients who have not been treated with an anticholinergic within the last year are to be considered for inclusion •Contraindications listed in the Instructions for Use/Summary of Product Characteristics for Ventilat® metered dose inhaler</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>